Normal view MARC view ISBD view

Cost-effectiveness of pazopanib compared with sunitinib in metastatic renal cell carcinoma in Canada.

Amdahl, J

Cost-effectiveness of pazopanib compared with sunitinib in metastatic renal cell carcinoma in Canada. [electronic resource] - Current oncology (Toronto, Ont.) Aug 2016 - e340-54 p. digital

Publication Type: Journal Article

ISSN: 1198-0052

Standard No.: 10.3747/co.23.2244 doi

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)